BioSpace News Archive

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has submitted a new drug application (JNDA) to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for approval of oral, once daily berotralstat for the prophylactic treatment of hereditary angioedema (HAE).

ILC Dover, Inc. announced that it has partnered with New York-based New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management.

Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious diseases and cancer, announces that it has finalized the acquisition of a novel Hepatitis B Virus (HBV) potential treatment or cure from Seraph Research Institute.

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, announced that its commercially available and over-the-counter gastrointestinal and digestive health supplement Travelan

CVS Health announced upcoming changes to its Board of Directors. Richard “Dick” Swift, Richard Bracken and Mark Bertolini will not stand for reelection at the company’s 2020 Annual Meeting.

- The CATALYST trial will examine Abbott’s Amplatzer™ Amulet™ device compared to non-vitamin K oral anticoagulants, the current standard in attempting to lower stroke and bleeding risks for patients with atrial fibrillation

We are excited to announce our newest addition to the Citadel Healthcare family, The Citadel of Skokie

The State University of Campinas (Unicamp) and Entourage Phytolab have just announced an agreement for the development of research on cannabis varieties for medicinal use.

The California Pharmacists Association’s Board of Trustees announced that Susan Bonilla has been appointed Chief Executive Officer of the nation’s largest, statewide pharmacy association representing the profession and all pharmacy practice settings.

Q3 Medical Devices Limited based in Dublin, Ireland announced that the Hong Kong Stock Exchange has approved Ireland as an acceptable jurisdiction for the purpose of Irish companies seeking to list on the Exchange.